Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials

Comparative cardiovascular outcomes in the era of novel anti-diabetic agents: a comprehensive network meta-analysis of 166,371 participants from 170 randomized controlled trials

Abstract Background Cardiovascular (CV) safety of one anti-diabetic medication over another remains partially delineated. We sought to assess the comparative effect on CV outcomes among novel anti-diabetic agents. Methods This study was registered with the International Prospective Register of Syste...

Full description

Bibliographic Details
Main Authors: Xiao-dong Zhuang, Xin He, Da-ya Yang, Yue Guo, Jian-gui He, Hai-peng Xiao, Xin-xue Liao
Format: Article
Language:English
Published: BMC 2018-06-01
Series:Cardiovascular Diabetology
Subjects:
Cardiovascular
Meta-analysis
Mortality
Diabetes
Agents
Online Access:http://link.springer.com/article/10.1186/s12933-018-0722-z

Internet

http://link.springer.com/article/10.1186/s12933-018-0722-z

Similar Items